U.S. federal trademark · Serial No. 87140304 · Reg. No. 5472525
a full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute enterocolitis, and duodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids)
Surgical apparatus and instruments for use in surgery; medical apparatus and instruments for use in treating medical conditions, namely, cancer and symptoms related to cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.